Details for Patent: 7,470,720
Summary for Patent: 7,470,720
| Title: | Methods and compositions for use in treating cancer |
| Abstract: | The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer. |
| Inventor(s): | Bruce A. Littlefield, Murray J. Towle |
| Assignee: | Eisai R&D Management Co Ltd |
| Application Number: | US10/687,526 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 7,470,720
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,470,720
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1087960 | ⤷ Start Trial | C300493 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1087960 | ⤷ Start Trial | 91854 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 1087960 | ⤷ Start Trial | CA 2011 00022 | Denmark | ⤷ Start Trial |
| European Patent Office | 1087960 | ⤷ Start Trial | SPC026/2011 | Ireland | ⤷ Start Trial |
| European Patent Office | 1087960 | ⤷ Start Trial | 1190021-4 | Sweden | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
